Biologics in Therapy
Biologics in Therapy is a fully open access, internationally peer-reviewed, rapid-publication (peer review in 2 weeks, published 3-4 weeks from acceptance) journal. Emphasis is placed on the publication of high-quality articles covering preclinical, clinical (phase 1-4), and postmarketing studies on new and existing therapies using biological products including vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications. Each paper is accompanied by a bulleted slide summary to give a time-efficient overview of the content. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Biologics in Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/2.5
3 Volumes 4 Issues 21 Articles available from 2011 - 2013Browse Volumes & Issues
- Journal Title
- Biologics in Therapy
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Volume 1 / 2011 - Volume 3 / 2013
- Print ISSN
- Online ISSN
- Springer Healthcare
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.